Clinical Trial Results

Showing: All studies [change]
Condition: Alzheimer's Location: Cambridge, Massachusetts 25 trials found
New Search
Filter
Trial Phase
Study Type
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
TMS for Cognitive Decline in Aging and Preclinical AD
NAINTERVENTIONAL Boston, Massachusetts
RECRUITING
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
PHASE2INTERVENTIONAL Boston, Massachusetts
RECRUITING
Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
NAINTERVENTIONAL Boston, Massachusetts
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
PHASE3INTERVENTIONAL Fullerton, California +4 more
RECRUITING
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
PHASE4INTERVENTIONAL Irvine, California +4 more
RECRUITING
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
PHASE1, PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
N/AOBSERVATIONAL Belmont, Massachusetts
RECRUITING
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
PHASE2INTERVENTIONAL Long Beach, California +4 more
RECRUITING
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
PHASE3INTERVENTIONAL Long Beach, California +4 more
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
The BRAIN App (Phase 2 SBIR)
NAINTERVENTIONAL Winchester, Massachusetts
RECRUITING
Making Connections Thru Music
NAINTERVENTIONAL Winchester, Massachusetts +1 more
RECRUITING
[18F]PI-2620 Phase 3 Histopathological Study
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
PHASE2INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
PHASE2INTERVENTIONAL Chino, California +4 more
RECRUITING
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
N/AOBSERVATIONAL Atlantis, Florida +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type